This gives investors regulated exposure to Ethereum, along with yield and leverage strategies unavailable to spot Ethereum ETFs.
Standard Chartered highlighted that these companies benefit from a structural edge over U.S.-regulated ETFs, which are prohibited from staking.
Many of the treasury firms have staked the majority of their ETH, raised capital through private placements or convertible debt, and deployed assets into on-chain protocols to generate additional returns.
According to the report, these companies are exploiting regulatory inefficiencies and retail limitations. As a result, they often trade above net asset value, serving as de facto ETH ETFs with built-in yield, operational flexibility, and balance sheet leverage.
Standard Chartered documented a broad industry shift, with companies in biotechnology, energy, and semiconductors repurposing operations to adopt ETH treasury strategies. Moss Genomics, Centaurus Energy, and IntChains Group were cited as examples of this cross-sector trend.
The report projected that if current trends persist, treasury companies could eventually control up to 10% of the ETH supply. This would represent a 10x increase from current levels and solidify Ethereum’s role in corporate capital allocation strategies.
Standard Chartered framed Ethereum treasuries as an emerging counterpart to ETFs, but with distinct structural advantages: staking income, composability, and strategic equity optionality in public markets.
If institutional demand continues alongside favorable regulatory conditions, ETH treasury firms could become a long-term fixture in the crypto-financial ecosystem.
